Stepwise differentiation of follicular helper T cells reveals distinct developmental and functional states.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
24 Nov 2023
Historique:
received: 05 04 2023
accepted: 08 11 2023
medline: 27 11 2023
pubmed: 25 11 2023
entrez: 24 11 2023
Statut: epublish

Résumé

Follicular helper T (Tfh) cells are essential for the formation of high affinity antibodies after vaccination or infection. Although the signals responsible for initiating Tfh differentiation from naïve T cells have been studied, the signals controlling sequential developmental stages culminating in optimal effector function are not well understood. Here we use fate mapping strategies for the cytokine IL-21 to uncover sequential developmental stages of Tfh differentiation including a progenitor-like stage, a fully developed effector stage and a post-effector Tfh stage that maintains transcriptional and epigenetic features without IL-21 production. We find that progression through these stages are controlled intrinsically by the transcription factor FoxP1 and extrinsically by follicular regulatory T cells. Through selective deletion of Tfh stages, we show that these cells control antibody dynamics during distinct stages of the germinal center reaction in response to a SARS-CoV-2 vaccine. Together, these studies demonstrate the sequential phases of Tfh development and how they promote humoral immunity.

Identifiants

pubmed: 38001088
doi: 10.1038/s41467-023-43427-4
pii: 10.1038/s41467-023-43427-4
pmc: PMC10674016
doi:

Substances chimiques

COVID-19 Vaccines 0
Transcription Factors 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7712

Subventions

Organisme : NIAID NIH HHS
ID : P01 AI056299
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI153124
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI158413
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI158175
Pays : United States

Informations de copyright

© 2023. The Author(s).

Références

Methods Mol Biol. 2022;2380:175-185
pubmed: 34802131
Immunity. 2022 Feb 8;55(2):272-289.e7
pubmed: 35081372
Nat Immunol. 2019 Mar;20(3):326-336
pubmed: 30778252
Annu Rev Immunol. 2016 May 20;34:335-68
pubmed: 26907215
Curr Opin Immunol. 2020 Dec;67:68-74
pubmed: 33176227
Immunol Rev. 2020 Jul;296(1):104-119
pubmed: 32564426
Cell Rep. 2020 Oct 6;33(1):108232
pubmed: 33027650
FASEB J. 2016 Feb;30(2):761-74
pubmed: 26499265
Nat Immunol. 2019 Oct;20(10):1360-1371
pubmed: 31477921
Nature. 2006 May 11;441(7090):235-8
pubmed: 16648838
J Exp Med. 2010 Feb 15;207(2):365-78
pubmed: 20142430
Nat Commun. 2022 Feb 10;13(1):805
pubmed: 35145086
Nat Immunol. 2019 Feb;20(2):163-172
pubmed: 30643263
Blood. 2009 May 28;113(22):5536-48
pubmed: 19307668
Nature. 2018 Aug;560(7719):494-498
pubmed: 30089906
Cell Rep. 2017 Oct 3;21(1):208-221
pubmed: 28978474
J Clin Invest. 2014 Dec;124(12):5191-204
pubmed: 25347469
J Virol. 2013 Jul;87(13):7737-46
pubmed: 23637417
Nat Immunol. 2015 Sep;16(9):980-90
pubmed: 26214741
Nat Immunol. 2019 Feb;20(2):232-242
pubmed: 30643266
Nat Immunol. 2016 Dec;17(12):1436-1446
pubmed: 27695002
Nat Immunol. 2021 Aug;22(8):1020-1029
pubmed: 34312547
Immunity. 2022 Jan 11;55(1):115-128.e9
pubmed: 35021053
Trends Immunol. 2021 Apr;42(4):336-349
pubmed: 33663954
Nat Immunol. 2012 May;13(5):491-8
pubmed: 22466669
Nat Immunol. 2016 Oct;17(10):1197-1205
pubmed: 27573866
Cell Rep. 2016 Feb 23;14(7):1735-1747
pubmed: 26876184
Nature. 2021 Jul;595(7869):724-729
pubmed: 34234346
Immunity. 2022 Aug 9;55(8):1414-1430.e5
pubmed: 35896116
J Exp Med. 2022 Jan 3;219(1):
pubmed: 34792530
Proc Natl Acad Sci U S A. 2014 Aug 12;111(32):11792-7
pubmed: 25071203
Cell. 2021 Dec 22;184(26):6281-6298.e23
pubmed: 34875227
F1000Res. 2020 Jan 27;9:47
pubmed: 32789006
Cell Rep. 2022 Feb 22;38(8):110399
pubmed: 35139367
Nat Immunol. 2014 Jul;15(7):667-75
pubmed: 24859450
Am J Transplant. 2021 May;21(5):1893-1901
pubmed: 33421294
Science. 2021 Jul 16;373(6552):
pubmed: 34437125
J Immunol. 2019 Apr 15;202(8):2229-2239
pubmed: 30833348
J Exp Med. 2010 Feb 15;207(2):353-63
pubmed: 20142429
Nat Biotechnol. 2014 Apr;32(4):381-386
pubmed: 24658644
J Exp Med. 2019 Mar 4;216(3):605-620
pubmed: 30705058
Sci Immunol. 2021 May 28;6(59):
pubmed: 34049865
Nature. 2016 Sep 15;537(7620):417-421
pubmed: 27501248
Genome Biol. 2018 Dec 19;19(1):224
pubmed: 30567574
Immunity. 2019 May 21;50(5):1132-1148
pubmed: 31117010
Immunity. 2008 Jul 18;29(1):127-37
pubmed: 18602282

Auteurs

Manuel A Podestà (MA)

Transplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Renal Division, Department of Health Sciences, Università degli Studi di Milano, Milano, Italy.

Cecilia B Cavazzoni (CB)

Transplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Benjamin L Hanson (BL)

Transplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Elsa D Bechu (ED)

Transplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Garyfallia Ralli (G)

Transplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Rachel L Clement (RL)

Transplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Hengcheng Zhang (H)

Transplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Pragya Chandrakar (P)

Transplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Jeong-Mi Lee (JM)

Transplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Tamara Reyes-Robles (T)

Exploratory Science Center, Merck & Co., Inc., Cambridge, MA, 02141, USA.

Reza Abdi (R)

Transplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Alos Diallo (A)

Department of Immunology, Harvard Medical School, Boston, MA, USA.

Debattama R Sen (DR)

Center for Cancer Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA.

Peter T Sage (PT)

Transplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. psage@bwh.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH